The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling.

We have shown that vitronectin (Vn) binding to a cysteine loop sequence within the extracellular domain of the beta3-subunit (amino acids 177-184) of alphaVbeta3 is required for the positive effects of Vn on IGF-I signaling. When Vn binding to this sequence is blocked, IGF-I signaling in smooth muscle cells is impaired. Because this binding site is distinct from the site on beta3 to which the Arg-Gly-Asp sequence of extracellular matrix ligands bind (amino acids 107-171), we hypothesized that the region of Vn that binds to the cysteine loop on beta3 is distinct from the region that contains the Arg-Gly-Asp sequence. The results presented in this study demonstrate that this heparin binding domain (HBD) is the region of Vn that binds to the cysteine loop region of beta3 and that this region is sufficient to mediate the positive effects of Vn on IGF-I signaling. We provide evidence that binding of the HBD of Vn to alphaVbeta3 has direct effects on the activation state of beta3 as measured by beta3 phosphorylation. The increase in beta3 phosphorylation associated with exposure of cells to this HBD is associated with enhanced phosphorylation of the adaptor protein Src homology 2 domain-containing transforming protein C and enhanced activation MAPK, a downstream mediator of IGF-I signaling. We conclude that the interaction of the HBD of Vn binding to the cysteine loop sequence of beta3 is necessary and sufficient for the positive effects of Vn on IGF-I-mediated effects in smooth muscle cells.

[1]  L. Maile,et al.  Insulin-like growth factor-i signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the β3-subunit of αVβ3 , 2006 .

[2]  J. Eipper-Mains,et al.  αvβ3 Integrins and Pyk2 Mediate Insulin-Like Growth Factor I Activation of Src and Mitogen-Activated Protein Kinase in 3T3-L1 Cells , 2005 .

[3]  L. Maile,et al.  Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. , 2005, Molecular biology of the cell.

[4]  S. Mohan,et al.  Fluid Shear Stress Synergizes with Insulin-like Growth Factor-I (IGF-I) on Osteoblast Proliferation through Integrin-dependent Activation of IGF-I Mitogenic Signaling Pathway* , 2005, Journal of Biological Chemistry.

[5]  J. Rhim,et al.  Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins , 2004, The Journal of cell biology.

[6]  J. Takagi,et al.  Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Maile,et al.  Integrin-Associated Protein Binding Domain of Thrombospondin-1 Enhances Insulin-Like Growth Factor-I Receptor Signaling in Vascular Smooth Muscle Cells , 2003, Circulation research.

[8]  L. Maile,et al.  The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. , 2003, Molecular biology of the cell.

[9]  L. Maile,et al.  Tyrosine Phosphorylation of the β3-Subunit of the αVβ3 Integrin Is Required for Membrane Association of the Tyrosine Phosphatase SHP-2 and Its Further Recruitment to the Insulin-Like Growth Factor I Receptor , 2003 .

[10]  P. McKeown-Longo,et al.  Vitronectin's Basic Domain is a Syndecan Ligand which Functions in transto Regulate Vitronectin Turnover , 2003, Cell communication & adhesion.

[11]  L. Maile,et al.  The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. , 2002, Endocrinology.

[12]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[13]  L. Maile,et al.  Regulation of Insulin-like Growth Factor I Receptor Dephosphorylation by SHPS-1 and the Tyrosine Phosphatase SHP-2* , 2002, The Journal of Biological Chemistry.

[14]  L. Maile,et al.  Insulin-like Growth Factor I Increases (cid:1) V (cid:2) 3 Affinity by Increasing the Amount of Integrin-associated Protein That Is Associated with Non-raft Domains of the Cellular Membrane* , 2002 .

[15]  L. Maile,et al.  Structural analysis of the role β3 subunit of the αVβ3 integrin in IGF-I signaling , 2001 .

[16]  R. Baserga.  The contradictions of the insulin-like growth factor 1 receptor , 2000, Oncogene.

[17]  D. Clemmons,et al.  Synthetic αVβ3 Antagonists Inhibit Insulin-Like Growth Factor-I-Stimulated Smooth Muscle Cell Migration and Replication1. , 1999, Endocrinology.

[18]  M. Shakibaei,et al.  Signal transduction by β1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor , 1999 .

[19]  R. Soldi,et al.  Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2 , 1999, The EMBO journal.

[20]  D. Clemmons,et al.  Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells , 1998 .

[21]  M. Crescenzi,et al.  α6β4 and α6β1 Integrins Associate with ErbB-2 in Human Carcinoma Cell Lines , 1997 .

[22]  E. Ruoslahti,et al.  αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF , 1997 .

[23]  J. Takagi,et al.  Changing Ligand Specificities of αvβ1 and αvβ3 Integrins by Swapping a Short Diverse Sequence of the β Subunit* , 1997, The Journal of Biological Chemistry.

[24]  K. Yamamoto,et al.  Porcine vitronectin, the most compact form of single-chain vitronectin: the smallest molecular mass among vitronectins was ascribed to deletion and substitution of base pairs, and proteolytic trimming of the peptide. , 1996, Journal of biochemistry.

[25]  D. Clemmons,et al.  Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Clemmons,et al.  Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin (*) , 1996, The Journal of Biological Chemistry.

[27]  D. Clemmons,et al.  Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. , 1995, Endocrinology.

[28]  E. Ruoslahti,et al.  Association of insulin receptor substrate-1 with integrins. , 1994, Science.

[29]  R. Timpl,et al.  Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. , 1993, The Journal of biological chemistry.

[30]  E. Ruoslahti,et al.  A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin , 1993, The Journal of cell biology.

[31]  E. Ruoslahti,et al.  Domain structure of vitronectin. Alignment of active sites. , 1984, The Journal of biological chemistry.

[32]  C. Peterson,et al.  A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. , 2005, Biochemistry.